Menu

Implen Launches New NanoPhotometer N120: The High Throughput Champion!

Implen GmbH is excited to announce the release of the NanoPhotometer® N120, an absorbance based UV/VIS Multi Channel Spectrophotometer.

Jun 7, 2019
Implen, Inc.

The instrument’s extremely compact and stand-alone design (20x20 cm) allows for rapid full scan analysis of up to 12 samples (2µl) at a time over a wide concentration range (2-8,000 ng/μl dsDNA). The N120 provides reliable data for the accurate determination of sample purity ratios, while reducing operational steps for the user by 33%. Powered by a 2.4 GHz Intel Celeron processor, the N120 significantly reduces measurement time providing high resolution full scan data in as little as 1.7 seconds per sample.

The NanoPhotometer® N120 features our unique and proprietary 12 Point Technology™ which consists of several positioning guides for single and multi-channel pipettes, patented illuminated sample windows as well as a software controlled animated sample processing grid to ensure convenient and error free sample application for the user.

Implen’s NPOS is ready for digital transformation by providing various options for database integration utilizing a REST API. The NanoPhotometer® can be easily incorporated into workflows by integration with any major LIMS provider for flexibility and added efficiency. Data export and device control can be executed directly through the LIMS interface on an external computer. 

The N120 can be combined with the new optional CFR21 software package providing FDA 21 CFR Part 11 compliance for electronic records and electronic signatures. This compliancy software, providing user management, is an ideal feature for the Pharmaceutical and Biotechnology industry which rely on proper electronic record keeping and data integrity.  

With the reliability and robust design you’ve come to know and trust, the N120 from Implen is free from recalibration saving the user significant cost over the lifetime of the instrument. 


July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.